Status:
TERMINATED
Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
- Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
Randomised study to compare the effect of r-Hu-EPO administration with transfusion of Red Blood cell concentrates and also with the administration of polyvitamins in anemic and tired patients presenti...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Both sexes
- 18-70 yrs
- metastatic or locally advanced cancer
- Life expectancy \> 3 months
- hemoglobin between 7 and 10 g/100ml
- no contraindication to r-Hu-EPO
- with written informed consent at entry time
Exclusion
Key Trial Info
Start Date :
February 1 2002
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT00180999
Start Date
February 1 2002
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Gustave-Roussy
Villejuif, France, 94800